Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis
Toxicological Sciences · 01.08.2026 · 209 (8)
DOI: 10.1093/toxsci/kfag090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicological Sciences, online erschienen am 29.07.2026. Verfasst von Robin Durnik und 9 weiteren Autor:innen. Beteiligte Einrichtung: RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic. Hauptthemen laut MEDLINE: Liver Cirrhosis, Adverse Outcome Pathways, Models, Biological. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RECETOX Research Infrastructure, Ministry of Education, Youth and Sports, Operational Programme Research, Development and Education.
Abstract (Originalsprache)
As toxicology shifts towards nonanimal testing, quantitative models are essential to predict adverse health effects from molecular or cellular perturbations. Quantitative Adverse Outcome Pathways (qAOPs) represent such models, building on mechanistic knowledge and quantifying the key event relationships (KERs) described in AOPs. Despite the recognized need, the number of qAOPs remains limited. Bayesian-based approaches are often chosen for developing qAOP for their flexibility, but most use discretized variables, limiting their predictive power. In addition, these models are mainly built from newly generated data, underexploiting the large amount of information available. This study successfully leverages data from public literature and presents an innovative framework based on continuous variables to develop a Bayesian-based quantitative model for a central KER towards liver fibrosis. The model predicts the probability of the expression fold change for two key markers of hepatic stellate cell activation (aSMA and COL1A1), given the effects on tissue injury, using in vitro data from several chemicals. We propose a newly developed workflow to assist in knowledge identification, organization, and extraction from scientific literature and chemical databases. Based on in vitro data and in vivo information from the Open TG-GATEs (Toxicogenomics Project-Genomics Assisted Toxicity Evaluation System) database, we estimate a biologically relevant range in COL1A1 fold change that indicates an activated state of stellate cells and high liver fibrosis odds ratios. Our study provides a case example of integrating published data and continuous variables to build a Bayesian-based model, which constitutes an essential step towards predicting liver fibrosis from in vitro data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- RECETOX, Faculty of Science, Masaryk University, Brno, 61137, Czech Republic.
- Division of Cell Systems and Drug Safety, Leiden Academic Centre for Drug Research, Leiden University, Leiden, 2333 CC, The Netherlands.
- Health & Functional Exposomics - HealthFex, Université Paris Cité, INSERM, Paris, 75006, France.
ORCID-Profile: Robin Durnik, Karine Audouze, Lola Bajard
Förderung
- RECETOX Research Infrastructure
- Ministry of Education, Youth and Sports
- Operational Programme Research, Development and Education
- CETOCOEN EXCELLENCE
- the European Union's Horizon 2020 Research and Innovation
- European Partnership for the Assessment of Risks from Chemicals (PARC)
- the Horizon Europe
- the European Union or HADEA
Zitieren
APA
Durnik, R., Juchelkova, T., Hecht, H., Winkelman, L. M. T., Beltman, J. B., Coumoul, X., Jornod, F., Audouze, K., Blaha, L., & Bajard, L. (2026). Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis. Toxicological Sciences, 209(8). https://doi.org/10.1093/toxsci/kfag090
Vancouver
Durnik R, Juchelkova T, Hecht H, Winkelman LMT, Beltman JB, Coumoul X, et al. Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis. Toxicological Sciences. 2026;209(8). doi:10.1093/toxsci/kfag090
BibTeX
@article{Durnik2026,
author = {Durnik, Robin and Juchelkova, Tereza and Hecht, Helge and Winkelman, Levi M T and Beltman, Joost B and Coumoul, Xavier and Jornod, Florence and Audouze, Karine and Blaha, Ludek and Bajard, Lola},
title = {Towards Bayesian-based quantitative adverse outcome pathways using in vitro data from open literature and continuous variables: a case example for liver fibrosis},
journal = {Toxicological Sciences},
year = {2026},
volume = {209},
number = {8},
doi = {10.1093/toxsci/kfag090}
}
EUVIMED